Meeting
2015 Gastrointestinal Cancers Symposium
Change of skeletal muscle index during the chemotherapy as a prognostic factor of survival in pancreatic cancer patients receiving palliative chemotherapy.
Authors
Younak Choi
Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
Younak Choi , Tae Yong Kim , Kyung-Hun Lee , Sae-Won Han , Do-Youn Oh , Seock-Ah Im , Tae-You Kim , Yung-Jue Bang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 363)
DOI
10.1200/jco.2015.33.3_suppl.363
Abstract #
363
Poster Bd #
C32
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Associations between BMI, morphomics and survival in 528 patients with metastatic pancreatic cancer.
First Author: Valerie Gunchick
Poster
2016 Gastrointestinal Cancers Symposium
Nutritional status and outcomes of older versus younger patients (pts) with metastatic pancreatic cancer (mPC).
First Author: Namrata Vijayvergia
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Clinical significance of CA125 in unresectable pancreatic cancer treated with first-line chemotherapy.
First Author: Iori Motoo
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Prognostic factors associated with survival in patients with pancreatic cancer treated on early phase immune-checkpoint inhibitor clinical trials.
First Author: Rishi Surana